NOVA MSC Bhd, a leading provider of industry-focused application software and services, has unveiled a strategic change in its leadership structure to accelerate transformation and reinforce its commitment to sustainable long-term growth.
As part of this transition, Lai Teik Kin will relinquish his role as group CEO to focus fully on driving the growth and profitability of the group’s key business segments, namely its Healthcare Business and Eyris Business units.
With a strong track record and deep domain expertise, Lai will continue to play a critical leadership role by remaining an executive director to spearhead innovation and execution within high-potential verticals.
To ensure continuity and to sharpen the group’s focus during this pivotal period, executive chairman Sunny Loh will assume the responsibilities of interim group CEO.
In this role, he will provide strategic leadership to ensure faster decision-making while directly overseeing implementation of the group’s on-going turnaround efforts.
“This leadership realignment is a natural next step in our transformation journey,” commented Loh. “We are taking decisive steps to strengthen operational discipline, empower our core business units and position the group for long-term, sustainable success.”
Improved financial, strategic position
Despite challenging market conditions, Nova MSC delivered an improved performance for the 12 months financial period ended March 31, 2025.
The group’s revenue rose to RM37.43 mil, reflecting a 13% rise from RM33.04 mil in the previous year.
The improved revenue was largely attributable to efficient project execution and successful completion of significant contracts during the year. Correspondingly, the group narrowed its net loss to RM5.0 mil from mil RM6.3 mil previously
The group continues to maintain a healthy financial position, supported by a strong cash reserve of RM27.6 mil and a solid order book standing at RM46.1 mil as of end-March 2025. This will enable it to seize strategic opportunities that align with its growth ambitions.
Above all else, Nova MSC has also announced a change in its financial year end from March 31, 2025 to June 30 2025 to align its financial reporting with the group’s long-term planning and restructuring cycles.
In essence, the group’s core focus now centred on healthcare, e-government, artificial intelligence (AI) and robotics with its flagship offerings such as the SELENA+ diagnostic system and emerging robotics initiatives continuing to gain traction, hence offering recurring and resilience against broader economic headwinds.
At 9.49am, Nova MSC was unchanged at 7.5 sen with 113,400 shares traded, thus valuing the company at RM162 mil. – May 30, 2025
